Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the safety and preliminary efficacy of Anatabloc in reducing the urge to smoke among daily smokers; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Anatabloc

Snippet

Sponsor: Rock Creek Pharmaceuticals, Inc. | Conditions: Tobacco Use Disorder, Tobacco Dependence | Phase 1 | Status: COMPLETED